Sintx Technologies (SINT) Competitors $3.42 +0.24 (+7.55%) (As of 03:04 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SINT vs. AEMD, STSS, CTCX, POAI, CHEK, NUWE, QNRX, HSCS, NDRA, and VEROShould you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include Aethlon Medical (AEMD), Sharps Technology (STSS), Carmell (CTCX), Predictive Oncology (POAI), Check-Cap (CHEK), Nuwellis (NUWE), Quoin Pharmaceuticals (QNRX), Heart Test Laboratories (HSCS), ENDRA Life Sciences (NDRA), and Venus Concept (VERO). These companies are all part of the "medical equipment" industry. Sintx Technologies vs. Aethlon Medical Sharps Technology Carmell Predictive Oncology Check-Cap Nuwellis Quoin Pharmaceuticals Heart Test Laboratories ENDRA Life Sciences Venus Concept Sintx Technologies (NASDAQ:SINT) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, community ranking, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership. Does the MarketBeat Community favor SINT or AEMD? Aethlon Medical received 182 more outperform votes than Sintx Technologies when rated by MarketBeat users. However, 61.02% of users gave Sintx Technologies an outperform vote while only 52.28% of users gave Aethlon Medical an outperform vote. CompanyUnderperformOutperformSintx TechnologiesOutperform Votes3661.02% Underperform Votes2338.98% Aethlon MedicalOutperform Votes21852.28% Underperform Votes19947.72% Do analysts rate SINT or AEMD? Aethlon Medical has a consensus target price of $7.00, indicating a potential upside of 1,650.00%. Given Aethlon Medical's stronger consensus rating and higher probable upside, analysts plainly believe Aethlon Medical is more favorable than Sintx Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sintx Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Aethlon Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is SINT or AEMD more profitable? Aethlon Medical has a net margin of 0.00% compared to Sintx Technologies' net margin of -358.79%. Sintx Technologies' return on equity of -140.68% beat Aethlon Medical's return on equity.Company Net Margins Return on Equity Return on Assets Sintx Technologies-358.79% -140.68% -78.29% Aethlon Medical N/A -160.36%-115.74% Do insiders & institutionals believe in SINT or AEMD? 18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are held by institutional investors. 0.0% of Sintx Technologies shares are held by insiders. Comparatively, 1.1% of Aethlon Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media prefer SINT or AEMD? In the previous week, Aethlon Medical had 3 more articles in the media than Sintx Technologies. MarketBeat recorded 14 mentions for Aethlon Medical and 11 mentions for Sintx Technologies. Aethlon Medical's average media sentiment score of -0.02 beat Sintx Technologies' score of -0.17 indicating that Aethlon Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sintx Technologies 1 Very Positive mention(s) 0 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aethlon Medical 2 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral Which has higher earnings and valuation, SINT or AEMD? Sintx Technologies has higher revenue and earnings than Aethlon Medical. Aethlon Medical is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSintx Technologies$2.63M0.98-$8.26M-$50.56-0.07Aethlon Medical$570K9.80-$12.21M-$2.82-0.14 Which has more volatility and risk, SINT or AEMD? Sintx Technologies has a beta of 1.37, meaning that its share price is 37% more volatile than the S&P 500. Comparatively, Aethlon Medical has a beta of 1.74, meaning that its share price is 74% more volatile than the S&P 500. SummaryAethlon Medical beats Sintx Technologies on 11 of the 18 factors compared between the two stocks. Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Get Sintx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SINT vs. The Competition Export to ExcelMetricSintx TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.57M$4.45B$4.99B$8.82BDividend YieldN/A41.17%7.68%4.07%P/E Ratio-0.0714.6183.1114.50Price / Sales0.9850.231,397.6888.61Price / CashN/A51.8933.1632.45Price / Book0.015.354.644.65Net Income-$8.26M$13.76M$117.31M$224.84M7 Day Performance44.30%16.52%-3.01%-1.01%1 Month Performance5.23%1.07%-4.13%-0.24%1 Year Performance-96.07%47.83%30.13%24.88% Sintx Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SINTSintx Technologies0.256 of 5 stars$3.42+7.5%N/A-96.3%$2.57M$2.63M-0.0743News CoverageAEMDAethlon Medical2.5175 of 5 stars$0.40flatN/A-76.2%$5.57M$570,000.00-0.1410Analyst ForecastSTSSSharps Technology0.8839 of 5 stars$2.65-5.7%N/AN/A$5.05MN/A-0.253News CoveragePositive NewsCTCXCarmell1.0126 of 5 stars$0.23-17.7%N/A-88.8%$4.85MN/A0.0014Gap DownPOAIPredictive Oncology2.4183 of 5 stars$0.69-6.8%N/A-76.2%$4.58M$1.78M-0.2330Analyst RevisionNews CoverageGap UpCHEKCheck-Cap1.306 of 5 stars$0.77-3.7%N/A-77.3%$4.53MN/A-0.2680Upcoming EarningsAnalyst ForecastShort Interest ↓NUWENuwellis2.9377 of 5 stars$1.80+1.1%N/A-93.6%$3.36M$9.01M-0.0259Gap DownHigh Trading VolumeQNRXQuoin Pharmaceuticals2.3885 of 5 stars$0.62+1.6%N/A-86.5%$3.13MN/A-0.154Gap UpHSCSHeart Test Laboratories2.476 of 5 stars$2.59-1.5%N/A-84.2%$2.40M$18,600.00-0.1210Short Interest ↑Gap UpNDRAENDRA Life Sciences3.8099 of 5 stars$4.54-14.2%N/A-100.0%$2.23MN/A0.0020Gap DownVEROVenus Concept0.9744 of 5 stars$0.31-11.6%N/A-83.3%$2.21M$69.81M-0.04410Gap Down Related Companies and Tools Related Companies AEMD Alternatives STSS Alternatives CTCX Alternatives POAI Alternatives CHEK Alternatives NUWE Alternatives QNRX Alternatives HSCS Alternatives NDRA Alternatives VERO Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SINT) was last updated on 11/19/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sintx Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sintx Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
